AQR Capital Management - ATEA PHARMACEUTICALS INC ownership

ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of ATEA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$91,059
-27.5%
30,353
-9.6%
0.00%
Q2 2023$125,627
-72.6%
33,590
-75.5%
0.00%
-100.0%
Q1 2023$459,221
-36.7%
137,081
-9.2%
0.00%
-50.0%
Q4 2022$725,771
+317.1%
150,888
+394.5%
0.00%
Q3 2022$174,000
-77.4%
30,512
-71.8%
0.00%
-100.0%
Q2 2022$769,000
-62.2%
108,297
-61.5%
0.00%
-50.0%
Q1 2022$2,032,000281,4750.00%
Other shareholders
ATEA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 1,265,631$27,186,00091.01%
Yu Fan 143,867$3,090,00034.92%
AJU IB Investment Co., Ltd. 1,745,331$37,490,00021.62%
Bain Capital Life Sciences Investors, LLC 5,615,659$120,624,0007.90%
Cormorant Asset Management, LP 6,411,355$137,716,0004.68%
Ally Bridge Group (NY) LLC 373,288$8,018,0001.99%
RA Capital Management 5,368,451$115,314,0001.85%
Omega Fund Management, LLC 746,868$16,043,0001.82%
CM Management, LLC 90,000$1,933,0001.40%
SECTORAL ASSET MANAGEMENT INC 538,884$11,575,0000.94%
View complete list of ATEA PHARMACEUTICALS INC shareholders